| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.0046 | 1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.00054 | 1 |